Skip to main content
. 2021 Apr 9;13(4):520. doi: 10.3390/pharmaceutics13040520

Figure 2.

Figure 2

List of clinical challenges that need to be addressed by chemoimmunotherapy for glioblastoma (created with BioRender.com).